Benzinga | Nov 10, 2021 06:08PM EST

Armata Pharmaceuticals Q3 EPS $(0.22) Up From $(0.31) YoY, Sales $1.25M Up From $288.00K YoY

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses of $(0.31) per share from the same period last year. The company reported $1.25 million in sales this quarter. This is a 334.38 percent increase over sales of $288.00 thousand the same period last year.